Hematology/Oncology · Alhambra, CA
NPI
1871537738
Since 2006
Specialty
Hematology/Oncology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
707 S Garfield Ave, Suite 304
Alhambra, CA, 91801
Phone (626) 588-2825
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.9M
86,465 services
Medicare patients, 2024
814
Average age 76
Drug cost, 2024
$11.1M
2,988 prescriptions
Company payments, 2025
$17.72
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eddie H Hu was code J0897 (injection, denosumab, 1 mg), 5,880 times for 26 patients. In total Eddie H Hu billed 86,465 services in 103 codes, and Medicare paid $1.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 5,880 | 26 | $20.21 | $119K |
| 99213 Office E&M - Established | Office | 2,219 | 663 | $67.82 | $150K |
| 85025 Blood Count | Office | 1,720 | 540 | $7.61 | $13K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 913 | 23 | $0.09 | $81.93 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 770 | 16 | $0.65 | $501 |
| 36415 Venipuncture Blood Collection | Office | 395 | 177 | $8.65 | $3,417 |
| 96372 Injection Administration | Office | 214 | 49 | $11.10 | $2,375 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 198 | 26 | $0.52 | $103 |
| 99214 Office E&M - Established | Office | 197 | 142 | $99.81 | $20K |
| 96375 Injection Administration | Office | 189 | 23 | $13.82 | $2,612 |
| 96367 Intravenous Infusion, Hydration | Office | 170 | 21 | $25.10 | $4,267 |
| 96413 Chemotherapy Administration | Office | 165 | 29 | $113.06 | $19K |
| 99203 Office E&M - New | Office | 160 | 160 | $82.74 | $13K |
| 99231 Hospital E&M - Subsequent | Facility | 102 | 33 | $40.08 | $4,088 |
| 96417 Chemotherapy Administration | Office | 102 | 16 | $56.49 | $5,762 |
By year: 2022 $1.9M for 98,436 services; 2023 $2.1M for 109,847 services; 2024 $1.9M for 86,465 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,720 | 540 | $7.61 | $13K |
| 36415 Venipuncture Blood Collection | 395 | 177 | $8.65 | $3,417 |
Medicare prescription drug claims, 2024
In 2024, the drug Eddie H Hu prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 206 prescriptions and refills. In total Eddie H Hu wrote 2,988 Medicare prescriptions that cost $11.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 206 | 206 | 25 | $3.4M |
| Letrozole Generic | 162 | 332 | 33 | $4,384 |
| Anastrozole Generic | 152 | 348 | 36 | $2,244 |
| Eliquis Apixaban | 111 | 157 | 22 | $91K |
| Prednisone Generic | 88 | 98 | 20 | $445 |
| Hydrocortisone Generic | 74 | 80 | 22 | $1,029 |
| Levothyroxine Sodium Generic | 72 | 164 | 16 | $555 |
| Xgeva Denosumab | 66 | 66 | Under 11 | $214K |
| Lorazepam Generic | 65 | 68 | 18 | $350 |
| Dexamethasone Generic | 62 | 68 | 19 | $781 |
| Mirtazapine Generic | 61 | 83 | 19 | $454 |
| Hydroxyurea Generic | 60 | 149 | 17 | $1,720 |
| Omeprazole Generic | 56 | 104 | 27 | $343 |
| Tenofovir Disoproxil Fumarate Generic | 54 | 113 | 17 | $18K |
| Abiraterone Acetate Generic | 47 | 49 | Under 11 | $64K |
Brand drugs: - claims; generic drugs: 1,979 claims; opioid claims: 49.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eddie H Hu $17.72 ($17.72 in general payments such as food, travel and fees) from 1 company. The largest payer was Novartis Pharmaceuticals Corporation with $17.72.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 1 | $17.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.